inSomaBio

About:

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

Top Investors: National Science Foundation, Y Combinator, North Carolina Biotechnology Center, Asymmetry Ventures, One North Carolina Small Business Program

Description:

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine. It offers genetically engineer protein-based materials that can mimic the naturally found elastin found in extracellular tissues. The company also offers reconstructive plastic surgeries and injectable materials.

Total Funding Amount:

$5.35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)insomabio.com

Founders:

Ashutosh Chilkoti, Stefan Roberts

Number of Employees:

11-50

Last Funding Date:

2024-06-12

IPO Status:

Private

Industries: